WeedHeadLines

Pennsylvania Governor to AG Sessions: Back Off!

 Breaking News
  • Marijuana and The Brain Very often we hear on the News new medical studies that confirm what was already known for thousands of years among herbalists. Cannabis seems to have an underestimated medical value. Researchers at the University of Bonn have ... Read more › The post Marijuana and The Brain appeared first on MedicalMarijuanaBlog.com....
  • Study: CBD Administration Reduces Blood Pressure Oral CBD administration is associated with reduced blood pressure in healthy volunteers, according to clinical trial data published online in the Journal of Clinical Investigation. Investigators from the University of Nottingham in the United Kingdom assessed the effects of a single oral dose of 600 mg of CBD extract versus placebo in nine male subjects. Cannabidiol administration reduced resting systolic blood pressure and stroke volume (the amount of blood pumped by the left ventricle of the heart in one contraction). Compared to placebo, CBD intake was associated with reduced BP levels following exercise and in response to stress. Increased heart rate was observed following CBD administration, but no “adverse events” were reported by participants either during or following the study sessions. Authors concluded: “Our data show that a single dose of CBD reduces resting blood pressure and the blood pressure response to stress, particularly cold stress, and especially in the post-test periods. This may reflect the anxiolytic and analgesic effects of CBD, as well as any potential direct cardiovascular effects. … Further research is also required to establish whether CBD has any role in the treatment of cardiovascular disorders such as a hypertension.” Full text of the study, “A single dose of cannabisiol reduces blood pressure in healthy volunteers in a randomized crossover study,” is online here....
  • Two Major Victories For Student Rights In Federal Courts Dan Viets speaking at a NORML conference Federal courts have recently rejected the actions of university and college administrators who sought to inflict suspicionless drug tests on students at a public college and to restrict the First Amendment rights of marijuana law reformers at a public university. Both decisions have important national implications. Linn Tech Student Drug Testing Case In 2011, Linn State Technical College administrators declared that they intended to drug test every student who applied for admission to the small, state-funded college located in Osage County, Missouri, a short distance east of Jefferson City. No other public college or university in America had pursued such a program. It seemed clear to those who follow such matters that college and university students have the same rights as other adults to be free from unreasonable searches and seizures. While private institutions are not bound by the restraints of the Fourth Amendment, public tax-supported institutions are. Nonetheless, Linn Tech seemed determined to pursue inflicting random, suspicionless drug testing on their students. Tony Rothert, the Legal Director of the ACLU of Missouri, filed suit against Linn Tech. I filed a “friend of the court” brief on behalf of Students for Sensible Drug Policy, working with Alex Kreit, a law professor from San Diego. U.S. District Court Judge Nanette Laughrey, sitting in Jefferson City, subsequently issued a decision prohibiting such testing, with a few narrowly-drawn exceptions for those participating in training programs involving heavy machinery or high-voltage electricity. Linn Tech appealed that decision to the Eighth U.S. Circuit Court of Appeals in St. Louis. Legal scholars were shocked when a three-judge panel of that Court later sided with Linn Tech. In a decision which many believed ignored legal precedent and logic, two of three judges on the panel which initially heard the case sided with Linn Tech. Mr. Rothert then filed for a rehearing of the case by the full 11-judge Court. Such hearings are rarely granted, but in this case, the Motion was granted. Following that rehearing, all but two of the judges on the full Court sided with the students and the ACLU, overturning the decision of the three-judge panel. Still not satisfied, Linn Tech squandered more public tax money pursuing a Petition for Certiorari with the United States Supreme Court. Civil libertarians were concerned that the current high Court might indeed overturn the Eighth Circuit if it had accepted that Petition for review. However, on June 5, 2017, the U.S. Supreme Court denied further review in this matter. Therefore, the decision of the Eighth U.S. Circuit Court is now the final decision in this matter. Linn Tech administrators have reluctantly acknowledged that they must now follow the Constitution and abandon their effort to impose suspicionless drug testing on their students. Iowa State University NORML Censorship Case In another important case closely watched by many across the nation, members of the NORML Chapter at Iowa State University in 2012 applied for approval to print t-shirts which contained the name of the university-recognized organization and included an image of the school’s mascot, “Cy, the Cyclone”. University administrators first approved those t-shirts, but when the ISU NORML Chapter asked to reprint them, the university caved in to pressure from legislative staff people who had complained that it appeared the university was supporting marijuana legalization. The Foundation for Individual Rights in Education (FIRE) filed suit on behalf of the officers of the Iowa State University NORML Chapter, alleging content and viewpoint discrimination. The lawsuit sought to prevent university administrators from treating the NORML Chapter differently from other university-recognized student organizations. The federal district court in Iowa sided with the students and against the university. The university appealed to the Eighth U.S. Circuit Court of Appeals in St. Louis, which issued a decision in February of this year upholding the federal district judge’s ruling. Iowa State University administrators then asked the Eighth U.S. Circuit Court to reconsider its decision. The Court did so, which caused many to fear that they might change their minds. However, on June 13, 2017, the Eighth U.S. Circuit Court reaffirmed its earlier decision and went even further, holding that university administrators who prevented the ISU NORML Chapter from using the university’s trademarked images were individually liable for their actions and could, therefore, be ordered to pay damages from their own pockets! Administrators at the University of Missouri in Columbia have taken similar actions in regard to the MU NORML Chapter. It is hoped that the decision of the Eighth U.S. Circuit will encourage MU administrators to reconsider their position. The federal appellate court sent a loud and clear message to university administrators that they are required to respect the Constitutional rights of students, including those who advocate for reform of the marijuana laws. While Iowa State could do as Linn Tech administrators did and continue to squander more public tax money pursuing an ill-considered position, it is not at all likely the U.S. Supreme Court would grant further review in this matter. Administrators at the University of Missouri in Columbia have taken similar actions in regard to the MU NORML Chapter. It is hoped that the decision of the Eighth U.S. Circuit will encourage MU administrators to reconsider their position. These two decisions have reaffirmed the rights of college and university students to be free from random, suspicionless drug testing and to speak out for drug law reform without censorship by administrators.....
  • Weekly Legislative Update 6/17/17 Welcome to this week’s edition of the NORML legislative roundup! At the Federal level, the biggest news this week was two-fold. First, in a letter made public by Tom Angell of Marijuana Moment, it was revealed that Attorney General Jeff Sessions wrote a private message to Congressional leadership requesting that they lift restrictions on the Department of Justice’s ability to prosecute medical marijuana in states that have legalized. This would overturn years of precedent and could result in the shutdown of lawful state medical programs, depriving patients of the ability to make healthcare decisions with their doctor. This revelation came the day before Deputy Attorney General Rod Rosenstein testified before Congress and stated “The question of whether it’s legal under federal law is resolved because Congress has passed a law — it’s illegal. Scientists have found that there’s no accepted medical use for it.” Which rolls us right into the second biggest Federal development: the reintroduction of the CARERS Act, which would codify protections for lawful state medical programs. Passage of CARERS 2017 would exempt from federal prosecution those who are engaged in the “production, possession, distribution, dispensation, administration, laboratory testing, recommending use, or delivery of medical marijuana” in instances where these activities comport with state law. At the state level, New Hampshire Governor Chris Sununu signed HB 157 into law on June 16. The law adds “moderate to severe chronic pain” as a qualifying illness for medical cannabis. The new law takes effect in 60 days. Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state. Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level. Thanks for all you do and keep fighting,Justin Priority Alerts FederalJoin The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws. Click here to email your Member of Congress to urge them to join the Congressional Cannabis Caucus Protecting Patients: Legislation has been reintroduced in the Senate, The Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017, to strengthen protections for those compliant with their state’s medical marijuana laws and to impose various changes to federal law. Passage of CARERS 2017 exempts from federal prosecution those who are engaged in the “production, possession, distribution, dispensation, administration, laboratory testing, recommending use, or delivery of medical marijuana” in instances where these activities comport with state law. Separate provisions in Act exclude cannabdiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinical trial research to better assess the safety and efficacy of medical cannabis. Click here to send a message to your Senators urging them to support and possible co-sponsor the CARERS Act of 2017 MaineLegislation (LD 764) is before Gov. Paul LePage that will prohibit medical cannabis patients from being denied organ transplants. The measure “prohibits a transplant evaluator from determining a qualifying patient to be unsuitable to receive an anatomical gift solely because the qualifying patient uses medical marijuana.” ME resident? Click here to send a message to Gov. LePage urging him to sign the bill. MassachusettsMembers of the House put forward amendments to The Regulation and Taxation of Marijuana Act. Among proposed changes to the law would more than double taxes on retail cannabis sales, from 12 percent to as much as 28 percent, strip local control away from municipal voters and unilaterally give local government officials the power to decide whether or not to ban marijuana facilities in their communities, and restrict the kinds of marijuana edibles products that may be sold and purchased by adults. MA resident? Send a message to your lawmakers telling them to enact Question 4 as passed in a timely manner. ...
  • First Meeting Of Trump’s Opioid Commission: Will It Be Effective? Today, the Office of National Drug Control Policy convened it’s first meeting of President Trump’s “Commission on Combating Drug Addiction and the Opioid Crisis.” The Commission is tasked with making recommendations for improving the Federal response to opioid misuse and abuse. Best evidence informs us that medical marijuana access is associated with reduced levels of opioid-related abuse, hospitalization, and mortality. Nonetheless, this administration continues to express skepticism with regard to the safety and efficacy of medical marijuana. Today in The Hill newspaper, NORML Deputy Director Paul Armentano writes: With opioid overdose deaths having risen four-fold since 1999, it is imperative that lawmakers and public health experts approach this issue with an open mind and remain willing to entertain all potential alternatives. For many patients, cannabis provides a safe and effective substitute for the use of opioids and other potentially harmful substances. Committee members should set their political ideologies aside and give strong consideration to this rapidly growing body of scientific evidence. You can read the full piece in The Hill by clicking here. It is crucial that our government hear from us. Click here to send a message to the Commission urging them to include medical marijuana as part of any national response to the opioid crisis....

Pennsylvania Governor to AG Sessions: Back Off!

June 15
15:00 2017

Pennsylvania Governor to AG Sessions: Back Off!

  • by Justin Strekal, NORML Political Director
    June 15, 2017
    Comments

    In a recent letter to Attorney General Jeff Sessions, Pennsylvania Governor Tom Wolf wrote a pointed letter regarding the Department of Justice and it’s posturing to implement a crackdown of lawful state medical marijuana programs.

    The full letter:

    Dear Attorney General Sessions:

    Last year, the Pennsylvania passed bipartisan legislation to legalize Medical Marijuana that I was proud to sign into law. The legislation was the result of conversations with Republicans and Democrats and fierce advocacy from families of children who were stricken with terrible illness that could be helped by Medical Marijuana.

    We talked to kids who suffer dozens of seizures in a given day. We met veterans who have seen absolute terror and seek relief from the effects of their post-traumatic stress. We approached the responsibility of providing relief to the people of Pennsylvania very thoughtfully.

    Since I signed the legislation, we have taken very careful and deliberate steps to implement the law so that those who are suffering can get relief while ensuring that the state is a responsible steward of the program.

    Given the bipartisan and medical consensus for Medical Marijuana in Pennsylvania and many other states, I am disturbed to know that you are actively pursuing a change in federal law to go after medical marijuana suppliers.

    We do not need the federal government getting in the way of Pennsylvania’s right to deliver them relief through our new medical marijuana program.

    Your action to undo the protections of the Rohrabacher-Farr amendment, which prevents the use federal funds to disrupt states’ efforts to implement “their own State laws that authorize the use, distribution, possession or cultivation of medical marijuana” is misguided.

    If you seek to further disrupt our ability to establish a legal way to deliver relief of medical marijuana to our citizens, I will ask the Attorney General of Pennsylvania to take legal action to protect our residents and state sovereignty.

    Sincerely,

    Governor Tom Wolf

    Attorney General Jeff Sessions Photo by Gage Skidmore

    Attorney General Jeff Sessions
    Photo by Gage Skidmore

    This comes in response to a recently revealed private letter that Jeff Sessions sent to Congressional leadership requesting that the DOJ be permitted to target and prosecute state-licensed medical cannabis facilities, currently prohibited by a spending rider known as the Rohrabacher-Blumenauer amendment.

    “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime,” Sessions wrote, “The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.”

    Jeff Sessions actually seems to believe that lawful medical marijuana patients, i.e. sick people, are causing the violent crime and contributing to transnational drug trafficking.

    Deputy Attorney General Rod Rosenstein was questioned about federal marijuana policy during a Senate Judiciary Committee hearing earlier this week and he brought up current DOJ policy and left the door wide open to a potential crackdown.

    “Jim Cole tried to deal with it in that memorandum and at the moment that memorandum is still in effect. Maybe there will be changes to it in the future but we’re still operating under that policy which is an effort to balance the conflicting interests with regard to marijuana,” stated Rosenstein, “So I can assure you that is going to be a high priority for me as the U.S. Attorneys come on board to talk about how to deal with that challenge in the states that have legalized or decriminalized marijuana, whether it be for recreational or medical use…”

    The Cole Memo, is a Justice Department memorandum, authored by US Deputy Attorney General James Cole in 2013 to US attorneys in all 50 states directs prosecutors not to interfere with state legalization efforts and those licensed to engage in the plant’s production and sale, provided that such persons do not engage in marijuana sales to minors or divert the product to states that have not legalized its use, among other guidelines.

    But while the Justice Department contemplates its next move, Wolf and other state politicians are taking action. Recently, Washington Gov. Jay Inslee (D), Colorado Gov. John Hickenlooper (D), Oregon Gov. Kate Brown (D) and Alaska Gov. Bill Walker (I) issued a letter to the new U.S. Attorney General and to Secretary of Treasury Mnuchin calling on them to uphold the Obama Administration’s largely ‘hands off’ policies toward marijuana legalization, as outlined in the Cole Memo.

    “Overhauling the Cole Memo is sure to produce unintended and harmful consequences,” the governors wrote. “Changes that hurt the regulated market would divert existing marijuana product into the black market and increase dangerous activity in both our states and our neighboring states.”

    Click here to send a message to your member of Congress to urge them to force the Department of Justice to respect state marijuana laws and then visit http://norml.org/act to support other efforts in your state and federally.

    PA resident? Click here to send a message to your state lawmakers to support the effort to decriminalize marijuana in the Keystone State.

    Posted in : Advocacy, GOVERNMENT, Jeff Sessions, LAW ENFORCEMENT, Policy
    Add Your Comment

Share

Related Articles

0 Comments

No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment